Navigation Links
Treatment corrects severe insulin imbalance in animal studies
Date:7/31/2008

Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.

"There is currently no effective medical treatment for children with the most common type of congenital hyperinsulinism," said study leader Diva D. De Len, M.D., a pediatric endocrinologist at The Children's Hospital of Philadelphia. "This type of congenital hyperinsulinism is caused by mutations in genes that encode important potassium channels in the pancreatic beta cells." The study team, from Children's Hospital and the University of Pennsylvania School of Medicine, published their report online on July 17 in the Journal of Biological Chemistry.

In congenital hyperinsulinism (HI), genetic mutations damage the insulin-secreting beta cells in the pancreas. Insulin levels rage out of control and severely reduce blood glucose, a condition called hypoglycemia. If untreated, hypoglycemia may cause irreversible brain damage or death in children. Congenital HI occurs in an estimated one in 50,000 U.S. children, with a somewhat higher incidence among certain groups, such as Ashkenazic Jews.

For the past 20 years, the standard medical treatment for some forms of HI has been the drug diazoxide, which controls insulin secretion by opening up crucial potassium channels in beta cells. However, this drug does not work in the most common and severe forms of HI, in which mutations prevent those channels from forming.

When the abnormal beta cells are confined to a discrete portion of the pancreas, as occurs in approximately half of HI cases, precise surgery on the tiny organ can remove the lesion and cure HI. The Children's Hospital of Philadelphia is a world leader in diagn
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6050
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Video released of rapid Alzheimers improvement after new immune-based treatment
2. Fertility treatment in developing countries; a cycle of IVF for less than $200
3. New treatment approach promising for lymphoma patients in the developing world
4. Treatment delays result in poor outcomes for men with breast cancer
5. Counting tumor cells in blood predicts treatment benefit in prostate cancer
6. Stroke study reveals key target for improving treatment and suggests that Gleevec may help
7. Hypertension treatment effective in reversing vascular damage
8. Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment
9. Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment
10. Novel therapeutic strategy for colon cancer treatment
11. New ballast treatment could protect Great Lakes fish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
(Date:6/16/2015)... 16, 2015 Fingerprint Cards has received ... in the company,s portfolio from one of its module partners ... mainly take place during the third quarter 2015. The sensors ... . Jörgen Lantto, CEO of FPC, comments: ...   growing interest from smartphone OEMs in integrating touch fingerprint ...
(Date:6/12/2015)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announced the United States Patent ... and identify participants of a video visitation session ... system can: , Identify that the ... process is actually the person participating in the ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... VA Cartilage tympanoplasty can be performed successfully in ... according to a study in the February 2013 issue ... tympanoplasty is a frequently performed procedure with varying reported ... In general, tympanic membrane repair success in children is ...
... 31, 2013 RayBiotech, Inc. announced today that it ... Health Research Institute (BSHRI) of Sun City, Arizona.  Under ... services for the biochemical analysis of disease markers in ... be on the characterization of key biomarkers for the ...
... along with the journal Science , today announces ... Science & Technology Visualization Challenge, a highly competitive contest ... Science magazine is published by the American Association ... received more than 200 entries from 18 countries, including ...
Cached Biology News:RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute 2RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute 3Winners of 10th annual International Science & Technology Visualization Challenge announced 2Winners of 10th annual International Science & Technology Visualization Challenge announced 3
(Date:7/7/2015)... 2015 Genes in Space, a nation-wide ... landing at New England Biolabs® (NEB®) along with ... scientific exploration and celebration, on Thursday, July 9 ... Boeing®, The Center for Advancement of Science in ... to design an experiment to solve a real-life ...
(Date:7/7/2015)... ... July 07, 2015 , ... bioLytical Laboratories Inc. announced ... was accepted for presentation at the 8th Annual International AIDS Society (IAS) Conference ... Wednesday, July 22nd from 1:00 pm to 2:00pm Pacific Standard Time at the ...
(Date:7/7/2015)... 2015   Moleculera Labs today announced ... from the Oklahoma Center for the Advancement of ... development and clinical validation of new diagnostic testing ... in patients experiencing neuropsychiatric disorders such as depression, ... to assist physicians in identifying the subset of ...
(Date:7/7/2015)... , ... July 07, 2015 , ... CSM, a leading ... as Vice President of Finance. Morse has an extensive background in financial management and ... the CSM team. In his new role, Morse will oversee all financial areas of ...
Breaking Biology Technology:Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2bioLytical to Present Findings of Early HIV Detection 2bioLytical to Present Findings of Early HIV Detection 3Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3CSM Appoints Michael Morse as Vice President of Finance 2
... Medtech Company Strengthens Board as Lead Products Approach ... ... technology company,BioCeramic Therapeutics Ltd is delighted to announce that Sir Richard Sykes,has ... Chairman of pharmaceuticals company GlaxoSmithKline plc, takes up,the post with immediate effect., ...
... announced,today that it will present at the 3rd annual ... PM PDT (5:30 PM EDT) at the Hyatt Regency,La ... C.M.C., Director of Finance, will present an,overview of Medical ... development and commercialization of Neutron Cancer Diagnostics. Its,ONCOSENSOR(TM), a ...
... EAST BRUNSWICK, N.J., Oct. 24 Savient,Pharmaceuticals, Inc. ... company will,release financial results for the third quarter ... November 5, 2008., Christopher Clement, President and ... and Chief Financial Officer will host an,investment community ...
Cached Biology Technology:Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman 2BioAtom Inc. To Present at BIOCOM Investor Conference 2008 2Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008 2
... Error-free cloning of BAC (100+kb), fosmid (40kb), ... insert stability than any othe BAC vector. ... high yields and easy recombinant DNA purification. ... transcription-free (pSMART VC) vectors for the highest ...
...
... to Sf-900 II SFM.Sf21 ... from Spodoptera frugiperda (Fall ... (1). The Sf21 cells ... suspension culture in Sf-900 ...
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
Biology Products: